BMRA240517P7500
- 6.90
- 0.000.00%
Biomerica Newsroom
Express News | Biomerica Announces InFoods Pilot Launch With An 1,000-Member Physician Group
Biomerica Announces InFoods IBS Pilot Launch With Prominent 1,100 Member Physician Group Commencing June 2024
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis
Express News | Biomerica Inc: Under Sales Agreement, Co May Offer and Sell From Time to Time up to an Aggregate of $5.5 Mln of Shares of Co's Common Stock
Express News | Biomerica Inc: Entered Into at Market Issuance Sales Agreement With Ef Hutton LLC and R.f. Lafferty & Co
Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE
Biomerica (BMRA) said Monday it has a multiyear exclusive distribution deal with an undisclosed health-care conglomerate in the United Arab Emirates, starting with an order for home tests for colorect
Express News | Biomerica Shares Are Trading Higher After the Company Announced an Exclusive Distribution Agreement With a UAW Healthcare Conglomerate
Biomerica Jumps on Signing Multi-year Distribution Deal With Major UAE Healthcare Company
Express News | Biomerica Announces Multi-Year Exclusive Distribution Agreement With A UAE Healthcare Conglomerate, Commencing With An Initial Order For EZ Detect And Aware Products
Express News | Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening With Exclusive Multi-Year Distribution Agreement
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47
Biomerica Advances IBS Treatment With InFoods Product, Expands Physician Network Nationwide
Biomerica, Inc. (NASDAQ:BMRA), (the "Company") a global provider of advanced medical products is pleased to announce advancements in the roll out of the inFoods IBS product.Expansion Into New Offices
Express News | Biomerica Inc: Receives Notice of Allowance for Five New Patents in Europe, Canada and Japan
Express News | Biomerica Inc: in Discussions for Launch of Infoods Ibs With Large Non-Gi Physician Groups Opening New Market for Product
Express News | Biomerica Provides Update on Infoods® Ibs Expansion
Express News | Reported Late Friday, Biomerica Q3 EPS $(0.11) Up From $(0.12) YoY, Sales $1.02M Down From $1.11M YoY
Biomerica GAAP EPS of -$0.11, Revenue of $1M
Express News | Biomerica Q3 Revenue USD 1 Million
Biomerica Reports Third Quarter 2024 Financial Results
Biomerica, Inc. (Nasdaq: BMRA), (the "Company") a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2024 ended February 29, 2024.
Express News | Biomerica Received Decision Grant European Patent Number EP3497447 Titled "COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTING"
Biomerica InFoods IBS Data to Be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
Collaborators at the University of Michigan will present new Data on InFoods IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical SessionIRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomeric